NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-105.47%
↑ 31% vs avg
Percentile
P15
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-151.95%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -105.47% |
| Q3 2025 | -1.94% |
| Q2 2025 | -2440.76% |
| Q1 2025 | -132.30% |
| Q4 2024 | 106.79% |
| Q3 2024 | -13.83% |
| Q2 2024 | -7.64% |
| Q1 2024 | 42.64% |
| Q4 2023 | -29.93% |
| Q3 2023 | 3.87% |
| Q2 2023 | 17.38% |
| Q1 2023 | -6.38% |
| Q4 2022 | -468.18% |
| Q3 2022 | 135.37% |
| Q2 2022 | 18.83% |
| Q1 2022 | -20.95% |
| Q4 2021 | -32.76% |
| Q3 2021 | 10.99% |
| Q2 2021 | 2.63% |
| Q1 2021 | -25.09% |
| Q4 2020 | -980.33% |
| Q3 2020 | 117.32% |
| Q2 2020 | 2.46% |
| Q1 2020 | -3.65% |
| Q4 2019 | -7.65% |
| Q3 2019 | 33.71% |
| Q2 2019 | 7.77% |
| Q1 2019 | -168.21% |
| Q4 2018 | 25.12% |
| Q3 2018 | -32.80% |
| Q2 2018 | -19.00% |
| Q1 2018 | 1.19% |
| Q4 2017 | -0.32% |
| Q3 2017 | -6.09% |
| Q2 2017 | -60.22% |
| Q1 2017 | -99.63% |
| Q4 2016 | -2241.08% |
| Q3 2016 | 200.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 100.00% |